News | Computed Tomography (CT) | December 03, 2020

The company’s ClearRead Xray Confirm (Enhanced) and ClearRead CT – breakthrough lung nodule detection applications­ – have received clearance for sale in Australia

The company’s ClearRead Xray Confirm (Enhanced) and ClearRead CT – breakthrough lung nodule detection applications­ – have received clearance for sale in Australia

December 3, 2020 — Riverain Technologies, a U.S.-based developer of artificial intelligence (AI)-powered software that analyzes chest X-rays and computed tomography (CT) images – announced Wednesday that the Therapeutic Goods of Australia (TGA) cleared more of the company’s AI solutions for sale and distribution in Australia, including ClearRead CT and ClearRead Xray Confirm (Enhanced). These solutions are joining ClearRead Xray Bone Suppress and ClearRead Xray Compare that have been TGA-cleared since 2009.

ClearRead solutions significantly improve a clinician’s ability to accurately and efficiently detect disease, suppressing vessels in thoracic CT and bone structures in chest X-ray images for earlier, more efficient detection of lung abnormalities. Powered by the most advanced machine learning and modeling methods available to the medical imaging market, the patented, FDA-cleared, CE marked, and now TGA-cleared software tools are deployable in the clinic or the Cloud:

  • ClearRead Xray applications improve reading efficiency and accuracy and optimize the diagnostic value of all portable and upright images.
  • ClearRead CT supports concurrent reading, allowing for faster reading with proven automatic nodule detection performance for all nodule types.

ClearRead solutions are in use globally, including Germany, Japan, Australia, Canada, and many institutions in the United States.

For more information: www.riveraintech.com


Related Content

News | Contrast Media

December 5, 2022 — Bracco Diagnostics Inc., a U.S. subsidiary of Bracco Imaging S.p.A., has announced results from a ...

Time December 05, 2022
arrow
News | RSNA

December 5, 2022 — With AI becoming an integral part of clinical radiology workflows, the data used to develop AI ...

Time December 05, 2022
arrow
News | Radiology Business

December 5, 2022 — IMV, part of Science and Medicine Group, the leading market research and business intelligence ...

Time December 05, 2022
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

Here is a recap of what ITN viewers found most interesting during the month of November: 1. Top 10 Predictions for ...

Time December 05, 2022
arrow
News | RSNA

December 3, 2022 — Results from its Orviglance Food Effect study were presented by Ascelia Pharma, a biopharmaceutical ...

Time December 03, 2022
arrow
News | Artificial Intelligence

December 2, 2022 — emtelligent, a leader in the development of clinical-grade natural language processing (NLP) software ...

Time December 02, 2022
arrow
News | Computed Tomography (CT)

December 2, 2022 — New CT technology outperforms conventional CT in detecting subtle damage in the lungs of patients ...

Time December 02, 2022
arrow
News | Artificial Intelligence

December 1, 2022 — VIDA Diagnostics, Inc. (VIDA), the leader in imaging intelligence, has announced the availability of ...

Time December 01, 2022
arrow
News | Artificial Intelligence

December 1, 2022 — Annalise.ai and Nuance announced that the global medical imaging AI company has joined the Nuance ...

Time December 01, 2022
arrow
News | Artificial Intelligence

December 1, 2022 — At the 2022 Radiological Society of North America (RSNA) Annual Meeting, Peter R. Eby, MD, of ...

Time December 01, 2022
arrow
Subscribe Now